AMWatch

DTU-spinout har rejst 15 mio. kr. til EU-lancering af første produkt

Medicoselskabet Nanovi tabte godt 10 mio. kr. sidste år og gik ind i 2018 med en negativ egenkapital på små 14 mio. kr. Men i løbet af sommeren rejste man 15 mio. kr., og det skal hjælpe selskabet med at bringe dets første produkt på markedet i Europa.

Photo: Nanovi PR

Det danske selskab Nanovi, der udspringer fra DTU og udvikler tumormarkører til brug i kræftbehandling, nærmer sig det tidspunkt, hvor man kan lancerere sit første produkt.

I løbet af sommeren sikrede man sig den finansiering, der skal gøre det muligt.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from AMWatch

Velliv dives into fintech venture

Collaboration with Upfin, the first venture fund dedicated to targeting Danish fintech companies, will give Velliv access to fintech investments also in the Nordics.

Oil services investments and inflows help BankInvest in Q1

Net inflows have exceeded expectations at BankInvest in Q1. The EUR 20bn manager has been criticized for some of the investments in its sustainable flagship product, but CEO Lars Bo Bertram is proud that the EUR 12bn fund has managed to beat its benchmark despite massive gains for oil and gas.

Related articles

Latest news

AMWatch job

See all jobs

See all jobs

Watch job

See all jobs

See all jobs

Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch